Nollywood set new highs in 2023: here are four of my favourite films of the year
By Ezinne Ezepue – Lecturer, University of Nigeria (Special to BHN) The Nigerian film industry, popularly known as Nollywood, was once seen as a mass producer of poor quality “home videos.” It’s now become known for increasingly slick films that are able to attract big budgets and compete at film festivals across the world. As (more…)...
Will AI Replace Programmers Sooner Than We Think?
The rise of Artificial Intelligence (AI) and machine-learning tools like ChatGPT is having a significant impact on the industry of web development. Therefore, you might be wondering: Will AI replace programmers? Let’s take a closer look at the current state of AI in web development. (more…)...
Being Black and pregnant in the Deep South can be a dangerous combination
By Lauren Sausser (Special to Black Headline News) O’laysha Davis was a few weeks shy of her due date when in mid-August she decided it was time to switch doctors. Davis had planned to give birth at a small community hospital about 20 minutes from her home in North Charleston, South Carolina. But that changed...
Why 14th Amendment bars Trump from office: A constitutional law scholar explains principle behind Colorado Supreme Court ruling
An expert breaks down the surmised basis of the Colorado Supreme Court By Mark A. Graber Mark A. Graber is a University System of Maryland Regents Professor of Law at the University of Maryland. Graber does not work for, consult, own shares in or receive funding from any company or organization that would benefit from...
China-Africa relations in 2023: key moments and events to remember
By Lauren Johnston (Special to BHN) In a year when headlines have been dominated by conflict in Europe and the Middle East, and geo-economic tensions between China and the West, China-Africa relations were, in comparison, a steady and stable norm. Having followed China-Africa relations for two decades, I wanted to flag a few key moments...
Black Ghosts: Noo Saro-Wiwa’s new book is a powerful reflection on Africans in China
By Janet Remmington Noo Saro-Wiwa is a celebrated Nigerian-born travel writer. Her latest book is Black Ghosts. It explores, with candor and compassion, the lives of several African economic migrants living in China, a group of people who are key to trade between the continents. Janet Remmington is a scholar of African travel writing and mobility,...
‘Unacceptable,’ senators call on GAO to probe FDA’s oversight of medical devices Philips CPAP recall
Sens. Dick Durbin and Richard Blumenthal sent a letter noting how the agency missed opportunities to protect the public from faulty medical devices. By Jonathan D. Salant, Pittsburgh Post-Gazette; Debbie Cenziper, ProPublica; and Michael D. Sallah, Pittsburgh Post-Gazette Two prominent U.S. senators are calling for a government investigation into the Food and Drug Administration’s oversight...
We Asked Readers About Our Content Quality. Here’s What We Learned
We recently ran an experiment across three of our blogs to better understand readers, what they think of our content, and how we can potentially improve it. In this post, we’re going through the why and how of our experiment, along with the raw data and our initial conclusions. (more…)...
COP28 agreement signals ‘beginning of the end’ of the fossil fuel era
By Black Headline News The United Nations Climate Change Conference (COP28) closed today with an agreement that signals the “beginning of the end” of the fossil fuel era by laying the ground for a swift, just and equitable transition, underpinned by deep emissions cuts and scaled-up finance. In a demonstration of global solidarity, negotiators from...
The FDA approves the first two cell-based gene therapies to cure the sickle cell anemia disease
However the therapy process cost over $2 million per treatment By Black Headline News Last week, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older. Additionally, one of these therapies, Casgevy,...